Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose aspirin for prevention of gastric cancer in Ardabil
IRCT201105082032N3Phase 3Completed
- Sponsor
- Ministry of Health and Medical Education
- Start
- Apr 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in gastric cancer (GC) comparing Aspirin with Placebo (2 arms). Primary endpoint: Gastric cancer event. Started Apr 2017; status: completed.
02
Drugs
aspirin
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on IRCT201105082032N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201105082032N3.